Radiopharm Theranostics Ltd
ASX:RAD
Intrinsic Value
The intrinsic value of one RAD stock under the Base Case scenario is 0.201 AUD. Compared to the current market price of 0.022 AUD, Radiopharm Theranostics Ltd is Undervalued by 89%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Radiopharm Theranostics Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Radiopharm Theranostics Ltd
Balance Sheet Decomposition
Radiopharm Theranostics Ltd
Current Assets | 44.4m |
Cash & Short-Term Investments | 36.4m |
Receivables | 6.3m |
Other Current Assets | 1.7m |
Non-Current Assets | 48.1m |
Long-Term Investments | 40k |
PP&E | 57.1k |
Intangibles | 48m |
Free Cash Flow Analysis
Radiopharm Theranostics Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Radiopharm Theranostics Ltd
Revenue
|
1.7m
AUD
|
Cost of Revenue
|
-1.9m
AUD
|
Gross Profit
|
-231.2k
AUD
|
Operating Expenses
|
-37.5m
AUD
|
Operating Income
|
-37.8m
AUD
|
Other Expenses
|
-4.2m
AUD
|
Net Income
|
-41.9m
AUD
|
RAD Profitability Score
Profitability Due Diligence
Radiopharm Theranostics Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Radiopharm Theranostics Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
RAD Solvency Score
Solvency Due Diligence
Radiopharm Theranostics Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Radiopharm Theranostics Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RAD Price Targets Summary
Radiopharm Theranostics Ltd
Dividends
Current shareholder yield for RAD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one RAD stock under the Base Case scenario is 0.201 AUD.
Compared to the current market price of 0.022 AUD, Radiopharm Theranostics Ltd is Undervalued by 89%.